To prove these findings, the researchers also demonstrated that GAS5 knockdown attenuated hepatic steatosis and lipid accumulation, thus reducing the NAFLD activity score in HFD mice. The gene discussed is GAS5; the disease is metabolic dysfunction-associated steatotic liver disease.